M
Mabqi at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
Mabqi takes part in 2 sessions at Festival of Biologics 2026 in Basel, and exhibits. Its program centres on new cancer therapies, including antibody-drug conjugates for blood cancers. Topics include a tumor-specific antibody-drug conjugate against CD30 and a therapy aimed at the ion channel TRPV6 that is designed to work across many cancer types.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
M Mabqi | |
Develops therapeutic antibodies and antibody-drug conjugates for cancer. | Booth Exhibiting (no floor booth listed) Talk Wed Oct 14 12:30 A Novel Pan-Cancer TRPV6-Targeted Therapy Driving Antitumor Activity Through Ion Channel Modulation Why an ion channel that helps tumors grow may be a drug target in many cancers, with lab and animal tests of a therapy. |
Instantly find 20 buyers from Mabqi
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction